1. Home
  2. GFAI vs ENLV Comparison

GFAI vs ENLV Comparison

Compare GFAI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • ENLV
  • Stock Information
  • Founded
  • GFAI 2018
  • ENLV 2005
  • Country
  • GFAI Singapore
  • ENLV Israel
  • Employees
  • GFAI N/A
  • ENLV N/A
  • Industry
  • GFAI Diversified Commercial Services
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • ENLV Health Care
  • Exchange
  • GFAI Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • GFAI 24.6M
  • ENLV 25.8M
  • IPO Year
  • GFAI N/A
  • ENLV 1995
  • Fundamental
  • Price
  • GFAI $1.03
  • ENLV $1.06
  • Analyst Decision
  • GFAI Strong Buy
  • ENLV Strong Buy
  • Analyst Count
  • GFAI 1
  • ENLV 2
  • Target Price
  • GFAI $4.50
  • ENLV $10.00
  • AVG Volume (30 Days)
  • GFAI 505.7K
  • ENLV 183.7K
  • Earning Date
  • GFAI 09-23-2025
  • ENLV 11-28-2025
  • Dividend Yield
  • GFAI N/A
  • ENLV N/A
  • EPS Growth
  • GFAI N/A
  • ENLV N/A
  • EPS
  • GFAI N/A
  • ENLV N/A
  • Revenue
  • GFAI $36,987,715.00
  • ENLV N/A
  • Revenue This Year
  • GFAI $5.66
  • ENLV N/A
  • Revenue Next Year
  • GFAI $4.69
  • ENLV N/A
  • P/E Ratio
  • GFAI N/A
  • ENLV N/A
  • Revenue Growth
  • GFAI 4.38
  • ENLV N/A
  • 52 Week Low
  • GFAI $0.76
  • ENLV $0.81
  • 52 Week High
  • GFAI $3.88
  • ENLV $2.10
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 37.20
  • ENLV 45.08
  • Support Level
  • GFAI $1.02
  • ENLV $1.03
  • Resistance Level
  • GFAI $1.08
  • ENLV $1.16
  • Average True Range (ATR)
  • GFAI 0.07
  • ENLV 0.05
  • MACD
  • GFAI -0.01
  • ENLV -0.00
  • Stochastic Oscillator
  • GFAI 10.95
  • ENLV 13.89

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: